# An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta

> **NCT00982124** · PHASE3 · COMPLETED · sponsor: **Shriners Hospitals for Children** · enrollment: 14 (actual)

## Conditions studied

- Osteogenesis Imperfecta

## Interventions

- **DRUG:** Zoledronic Acid

## Key facts

- **NCT ID:** NCT00982124
- **Lead sponsor:** Shriners Hospitals for Children
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2015-09
- **Final completion:** 2016-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2016-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00982124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00982124, "An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00982124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*